Ariad Investors Decry Bid To Nix Failed Leukemia Drug Suit
Ariad Pharmaceuticals Inc. shareholders urged a Massachusetts federal judge to not toss a consolidated class action over alleged false statements about Ariad's failed leukemia drug Iclusig, saying Wednesday that prior to...To view the full article, register now.
Already a subscriber? Click here to view full article